Home/SAB Biotherapeutics/David P. Pearson
DP

David P. Pearson

Chief Business Officer

SAB Biotherapeutics

SAB Biotherapeutics Pipeline

DrugIndicationPhase
SAB-142Type 1 DiabetesPhase 2
SAB-185COVID-19 (SARS-CoV-2)Phase 2/3
SAB-176InfluenzaPhase 1